Ajanta Pharma consolidated net profit rises 65.82% in the March 2024 quarter

Sales rise 19.53% to Rs 1054.08 crore

Net profit of Ajanta Pharma rose 65.82% to Rs 202.72 crore in the quarter ended March 2024 as against Rs 122.25 crore during the previous quarter ended March 2023. Sales rose 19.53% to Rs 1054.08 crore in the quarter ended March 2024 as against Rs 881.84 crore during the previous quarter ended March 2023.

For the full year,net profit rose 38.81% to Rs 816.17 crore in the year ended March 2024 as against Rs 587.98 crore during the previous year ended March 2023. Sales rose 12.45% to Rs 4208.71 crore in the year ended March 2024 as against Rs 3742.64 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales1054.08881.84 20 4208.713742.64 12 OPM %26.4016.94 -27.8520.93 - PBDT312.29185.07 69 1249.33876.05 43 PBT278.04152.05 83 1113.93745.25 49 NP202.72122.25 66 816.17587.98 39

Powered by Capital Market - Live News